About Ocimum Biosolutions
Ocimum Biosolutions is a company based in Hyderabad (India) founded in 2000 by Linga Reddy Venkata Subba Reddy. It operates as a Professional Services and SaaS (Software-as-a-Service). Ocimum Biosolutions has raised $41.99 million across 4 funding rounds from investors including International Finance Corporation, Kubera Cross-Border Fund and Kubera Partners. The company has 24 employees. Ocimum Biosolutions offers products and services including Biotracker™, Sciantis™, and BioExpress® System. Ocimum Biosolutions operates in a competitive market with competitors including BGI, Genewiz, CosmosID, Acclinate and Macrogen, among others.
- Headquarter Hyderabad, India
- Employees 24
- Founders Linga Reddy Venkata Subba Reddy
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ocimumbio.com
- Social LinkedIn X Facebook
- Legal Name Ocimum Biosolutions Ltd.
- Date of Incorporation 12 Mar, 2001
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1.6 Lakh
FY 2025 · +353% YoY
- Net Loss-₹87.4 Lakh
FY 2025 · -5364% margin
- EBITDA₹95,000
FY 2025 · 58% margin
- Total Equity Funding$41.99M (USD)
in 4 rounds
- Latest Funding Round$17M (USD), Series D
Jun 2013
- InvestorsInternational Finance Corporation
& 2 more
- Employee Count24
Associated legal entities of Ocimum Biosolutions
Ocimum Biosolutions operates through Ocimum Bio Solutions (India) Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ocimum Bio Solutions (India) Limited CIN U72100TG2001PLC036378 | Active | 12 Mar 2001 | Hyderabad, Telangana | ₹0.0 Cr | 24 | 3 | View details |
Products & Services of Ocimum Biosolutions
Ocimum Biosolutions offers a comprehensive portfolio of products and services, including Biotracker™, Sciantis™, and BioExpress® System.
Laboratory data and sample management is facilitated by Biotracker™.
Biologics process tracking and analytics are supported by Sciantis™.
Gene expression reference data is provided by BioExpress® System.
Funding Insights of Ocimum Biosolutions
Ocimum Biosolutions has successfully raised a total of $41.99M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $17 million completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $41.99M
- Total Rounds 4
- Last Round Series D — $17M
- First Round $2.17M
(Nov 2006)
- Investors Count 3
All 4 funding rounds of Ocimum Biosolutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2013 | $17M | Series D | – | Kubera Cross-Border Fund | – |
| Jan 2011 | $8M | Series C | – | IFC, Kubera Partners | – |
| Dec 2007 | $14.82M | Series B | $74.06M | Kubera Cross-Border Fund | |
| Nov 2006 | $2.17M | Series A | $8.69M | IFC | – |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2007 | $74.06M | •••••••• |
| Nov 2006 | $8.69M | •••••••• |
Last known valuation $74.06M (Dec 2007). 3 investors in total: 3 institutional.
Investors in Ocimum Biosolutions
Ocimum Biosolutions has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include International Finance Corporation, Kubera Cross-Border Fund and Kubera Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward US and India markets. | 2006 | kuberacrossborderfund.com | George Town, Cayman Islands | |
IFC is focused on private sector development in emerging markets. | 1956 | ifc.org | - | |
PE firm investing in North America,Europe & Asia | – | kuberapartners.com | Mumbai, India |
Investor details for Ocimum Biosolutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ocimum Bio Solutions (India) Limited (Ocimum Biosolutions)
Ocimum Bio Solutions (India) Limited is the primary company behind Ocimum Biosolutions. The board of Ocimum Bio Solutions (India) Limited currently have 3 directors; the longest-serving is Sujata Pammi, appointed in 2001. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sujata Pammi DIN 02470246 | Director | 12 Mar 2001 | 25 yrs 6 mo | Ocimum Bio Solutions (India) Limited |
| Venkata Subash Lingareddy DIN 00125240 | Whole-time director | 12 Mar 2001 | 25 yrs 6 mo | Ocimum Bio Solutions (India) Limited |
| Lingareddy Subba Reddy Venkata DIN 00135847 | Additional Director | 07 Feb 2025 | 1 yr 8 mo | Ocimum Bio Solutions (India) Limited |
People of Ocimum Biosolutions
2 people are tracked at Ocimum Biosolutions (2 in leadership); the tracked headcount is 24.
| Name | Role | Group |
|---|---|---|
Linga Reddy Venkata Subba Reddy | Co-Founder | Leadership |
Anand Sagar | CEO | Leadership |
Complete people profiles for Ocimum Biosolutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Ocimum Biosolutions
Figures of Ocimum Bio Solutions (India) Limited, the primary company behind Ocimum Biosolutions, for FY 2025. Revenue was ₹1.6 Lakh (+353% year on year). Net loss was -₹87.4 Lakh (-5364% margin). EBITDA was ₹95,000 (58% margin). Revenue has grown at a compounded annual rate of -70% over three years and -62% over five years.
- ₹1.6 LakhRevenue · FY 2025 · +353% YoY
- -₹87.4 LakhNet loss · -5364% margin
- ₹95,000EBITDA · 58% margin
- ₹21.89 CrPaid-up capital
- 24Employees (provident fund records)
- -70%Revenue CAGR, 3 years
- -62%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ocimum Bio Solutions (India) Limited are on its company page.
Detailed financial statements for Ocimum Biosolutions
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ocimum Biosolutions
4 dated milestones of Ocimum Biosolutions across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Ocimum Biosolutions is founded.
- Funding First funding round of $2.2M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series D, of $17.0M.
Competitors of Ocimum Biosolutions
Ocimum Biosolutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BGI, Genewiz, CosmosID, Acclinate and Macrogen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| cosmosid.com | 2008 | Rockville, United States | $7.32M | 31 | Next-generation sequencing technologies for microorganism detection are developed. | |
| acclinate.com | 2020 | Birmingham, United States | $11.99M | 43 | Clinical trial services are provided to the biopharma sector. | |
| macrogen.com | 1997 | Seoul, South Korea | – | – | Next-generation sequencing and genomics services are provided globally. | |
| transnetyx.com | 2000 | Memphis, United States | – | 150 | Automated genotyping services for murine cell lines are developed. | |
| centrilliontech.com | 2009 | Palo Alto, United States | $94.6M | 23 | Developer of DNA chips and molecular assays | |
| redcliffegenetics.com | 2017 | Noida, India | $63.21M | 2,104 | Diagnostic services are provided to research, healthcare, and industry partners. | |
| tataa.com | 2001 | Gothenburg, Sweden | – | – | Molecular analysis services for research and drug development are offered. |
Detailed competitors of Ocimum Biosolutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ocimum Biosolutions
Websites that share an audience with Ocimum Biosolutions (ocimumbio.com).
Websites whose visitors overlap most with Ocimum Biosolutions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cfgbiotech.com | 100% | – | – | View details | |
atlas-biolabs.de | atlas-biolabs.de | 100% | – | – | – |
entagen.com | entagen.com | 100% | – | – | – |
| genomixbiotech.com | 100% | – | – | View details | |
| tcgaresearch.org | 100% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Ocimum Biosolutions
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Ocimum Biosolutions
10 companies that operate in the same segment as Ocimum Biosolutions (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 713.57 M | – | – | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | – | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 508.73 M | – | – | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, France | USD 863.12 M | – | – | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | – | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | – | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ocimum Biosolutions
Ocimum Biosolutions was founded in 2000 and raised its 1st funding round 6 years after it was founded.
Ocimum Biosolutions is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Anand Sagar is the current CEO of Ocimum Biosolutions.
Ocimum Biosolutions is a funded company, having raised a total of $41.99M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.17M, raised on Nov 2006.
Ocimum Biosolutions has 24 employees.
The primary company behind Ocimum Biosolutions, Ocimum Bio Solutions (India) Limited, reported revenue of ₹1.6 Lakh for FY 2025, up 353% year on year.
Comprehensive life science informatics solutions are offered by Ocimum Biosolutions. Services include sample and data management through LIMS and biologics data systems. Genomics data analysis, such as gene expression and next-gen sequencing, is supported. Bioinformatics tools and databases like BioExpress and ToxExpress are maintained. The company serves industries including bioagri, biobanking, core facilities, and hospitals. Consulting in bio-IT and lab services for clinical trials are also provided. Focus is placed on delivering efficient management and analytical tools for scientific research.
Ocimum Biosolutions offers Biotracker™, Sciantis™, and BioExpress® System.
Ocimum Biosolutions has 3 investors. Key investors include International Finance Corporation, Kubera Cross-Border Fund, and Kubera Partners.
The valuation of Ocimum Biosolutions is $74.06M as of Dec 2007.
Ocimum Biosolutions operates through Ocimum Bio Solutions (India) Limited.